Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Mannatech, Incorporated
Mannatech Receives Wells Notice on Previously Disclosed Inquiry
September 28th, 2008
Mannatech, Incorporated ("Mannatech") (NASDAQ: MTEX), a leading developer and provider of dietary supplements and skin care solutions, announced that it and its Chief Financial Officer and the Chairman of Mannatech's Audit Committee have received a notification, commonly referred to as a "Wells Notice," from the staff of the Division of Enforcement (the "Staff") of the United States Securities and Exchange Commission (the "SEC") related to the timing and completeness of Mannatech's October 2007 disclosure regarding its dismissal of Grant Thornton LLP as its independent registered public accountants. The Wells Notice stems from an informal inquiry commenced by the SEC with respect to the...
Source: Pharma Investments, Ventures & Law Weekly (2008-09-28)
|
